Characterization of three newly established rat sarcoma cell clones

. 2012 Dec ; 48 (10) : 610-8. [epub] 20121113

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid23150138

Establishment of new animal models using selected cell lines with different behaviour is very important for cancer investigations. In this study, we describe three morphologically distinct rat sarcoma clones-C4, C7 and D6-isolated from the R5-28 cell line. Cells of all clones expressed vimentin, fibronectin, laminin, collagen IV and matrix metalloproteinases 2 and 9. However, desmin, cytokeratins 8 and 18, ZO-1 and desmoplakins I and II were not detected. Significant proliferative capacity was documented by proliferating cell nuclear antigen expression and BrdU positivity. Karyotype of the C4, C7 and D6 cells greatly differed from diploid chromosome number of normal rat somatic cells. High expression of three cytokines-monocyte chemoattractant protein 1, tissue inhibitor of metalloproteinases 1 and vascular endothelial growth factor-was observed in all three clones. However, they varied in concentration of chemokines associated with neutrophil migration and activation-cytokine induced neutrophil chemoattractant 2 and lipopolysaccharide induced CXC chemokine. The C4 clone showed spontaneous tumour regression in vivo that was associated with significant changes in lymphocyte subpopulations.

Zobrazit více v PubMed

Biochem Biophys Res Commun. 1989 Jul 31;162(2):694-700 PubMed

Folia Biol (Praha). 2003;49(1):33-9 PubMed

Indian J Cancer. 2011 Apr-Jun;48(2):246-51 PubMed

Exp Cell Res. 2004 Dec 10;301(2):158-67 PubMed

Australas J Dermatol. 1997 Jun;38 Suppl 1:S63-5 PubMed

Cancer Cell. 2002 Sep;2(3):175-8 PubMed

Dis Model Mech. 2010 Sep-Oct;3(9-10):557-66 PubMed

Histopathology. 1987 Jan;11(1):63-72 PubMed

Melanoma Res. 2009 Oct;19(5):275-82 PubMed

Cancer Sci. 2006 May;97(5):355-61 PubMed

Exp Cell Res. 2000 Dec 15;261(2):348-59 PubMed

Reprod Nutr Dev. 1998 Nov-Dec;38(6):683-95 PubMed

J Plast Reconstr Aesthet Surg. 2009 Feb;62(2):161-74 PubMed

Infect Immun. 2011 Jul;79(7):2567-77 PubMed

Cardiovasc Res. 2005 Feb 15;65(3):550-63 PubMed

Cancer Res. 2007 Mar 15;67(6):2800-8 PubMed

Cancer Immunol Immunother. 2001 Feb;49(12):649-62 PubMed

Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3652-6 PubMed

Int J Clin Exp Pathol. 2010 Apr 23;3(4):416-28 PubMed

Cancer Cell. 2009 Sep 8;16(3):173-4 PubMed

World J Surg. 1995 May-Jun;19(3):352-8 PubMed

J Cell Biol. 2009 Apr 6;185(1):11-9 PubMed

J Surg Oncol. 1986 Apr;31(4):229-34 PubMed

In Vitro Cell Dev Biol Anim. 2010 Feb;46(2):131-9 PubMed

J Biol Chem. 1995 Jul 14;270(28):16756-65 PubMed

J Dermatol Sci. 2000 Dec;24(3):203-11 PubMed

Semin Cancer Biol. 2002 Jun;12(3):197-207 PubMed

Am J Pathol. 2006 Mar;168(3):715-7 PubMed

J Plast Reconstr Aesthet Surg. 2008;61(2):165-71 PubMed

Genes Chromosomes Cancer. 2010 Jan;49(1):40-51 PubMed

J Immunol. 2005 Dec 15;175(12):8280-6 PubMed

Hum Pathol. 2000 May;31(5):532-8 PubMed

J Exp Med. 1990 Jun 1;171(6):2177-82 PubMed

Cytokine. 2004 Mar 21;25(6):239-45 PubMed

Exp Mol Pathol. 1991 Aug;55(1):30-7 PubMed

Ann Oncol. 2010 May;21(5):1106-11 PubMed

Nat Med. 2003 Jun;9(6):669-76 PubMed

Arch Pathol Lab Med. 2006 Aug;130(8):1199-207 PubMed

Cancer Treat Res. 2009;149:353-91 PubMed

Am J Pathol. 2004 Apr;164(4):1131-9 PubMed

Int J Cancer. 2003 Jun 20;105(3):340-6 PubMed

Cancer Gene Ther. 2004 Mar;11(3):186-93 PubMed

BMC Cancer. 2011 May 30;11:211:1-11 PubMed

Folia Biol (Praha). 2007;53(6):216-9 PubMed

Folia Biol (Praha). 2005;51(6):159-65 PubMed

Cancer Lett. 2008 Feb 18;260(1-2):180-6 PubMed

Semin Cancer Biol. 2000 Dec;10(6):415-33 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...